Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | +23.42% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.17 | N/A | +23.42% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future growth. They are focusing on operational improvements and customer engagement.
Management highlighted ongoing efforts to improve operational efficiency.
They emphasized a focus on enhancing customer engagement and satisfaction.
Teladoc's earnings report shows a mixed picture, with a narrower-than-expected loss per share but no revenue figures available. The stock reacted negatively, dropping 2.57%, likely due to the lack of revenue guidance and uncertainty about future performance. Investors may be concerned about the company's ability to drive growth in a competitive telehealth market.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ADEIA INC
Feb 20, 2024